Adenosine deaminase gene therapy

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAdenosine deaminase gene therapy
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAdenosine deaminase stimulants
TargetsAdenosine deaminase
Therapy Area/IndicationsAdenosine deaminase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenetic Therapy IncNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthGenetic Therapy Inc
Active IndicationsN/A
Inactive IndicationsAdenosine deaminase deficiency

Other Information

ATC CodeN/A
Related LinksN/A